Michael Giuliani
Net worth: 930 387 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Tyndall | M | 48 | 10 years | |
| Joe Capper | M | 61 | 1 years | |
| Douglas Rice | M | 58 | 1 years | |
| Daniel J. Speciale | M | - | 11 years | |
| Ricci Whitlow | F | 55 | 1 years | |
| Kate Surdez | F | - | 2 years | |
| Dirk Stevens | M | - | 3 years | |
| Matthew Notarianni | M | - | 2 years | |
| John R. Harper | M | - | 3 years | |
| Eric Smith | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marion Snyder | F | - | 9 years | |
| Sandra L. Hatten | F | 67 | 5 years | |
| Timothy Wright | M | 66 |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 5 years |
| Mark Trudeau | M | 62 | 9 years | |
| William A. Nuerge | M | 71 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 3 years |
| Angus Russell | M | 68 | 8 years | |
| Matthew Harbaugh | M | 53 | 6 years | |
| Charles Robert Evans | M | 77 | 8 years | |
| Phyllis Gardner | M | 73 | 3 years | |
| Don Bailey | M | 78 | 2 years | |
| Peter Carlson | M | 60 | 4 years | |
| David Carlucci | M | 69 | 9 years | |
| JoAnn Reed | F | 68 | 9 years | |
| J. Carroll | M | 74 | 9 years | |
| Nancy Lurker | F | 66 | 3 years | |
| Diane Gulyas | F | 67 | 5 years | |
| Joseph A. Zaccagnino | M | 77 | - | |
| Neil S. Yeston | M | 81 | 8 years | |
| Kneeland Youngblood | M | 69 | 9 years | |
| Virgil Thompson | M | 84 | - | |
| Melvin Booth | M | 79 | 5 years | |
| Robert Stein | M | 73 | 3 years | |
| Hugh M. Oneill | M | 60 | 9 years | |
| Barbara Bodem | F | 56 | 3 years | |
| Katherine Crewe | F | - | 7 years | |
| Thomas E. Berry | M | 74 | - | |
| Michael-Bryant Hicks | M | 49 | 2 years | |
| Marvin R. Haselhorst | M | - | - | |
| Jeffrey Patrick | M | 55 | 4 years | |
| Ronald Lloyd | M | 63 | 2 years | |
| Stan Micek | M | - | 3 years | |
| William Phelan | M | 53 | 5 years | |
| Matthew Mainer | M | 53 | 1 years | |
| Dawn M. von Rohr | F | - | 21 years | |
| Brian Elsbernd | M | 60 | 3 years | |
| Raymond Furey | M | 56 | - | |
| Karen Sheehy | F | 62 | - | |
| Thomas Englese | M | 50 | 4 years | |
| Walter J. Kaczmarek | M | 65 | 4 years | |
| David Keenan | M | - | - | |
| John E. Einwalter | M | 55 | - | |
| Barry C. Brandstetter | M | - |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | 4 years |
| Stephen Merrick | M | 63 | - | |
| Frank Scholz | M | 54 | 5 years | |
| Babatunde Otulana | M | 67 | 4 years | |
| Steven Romano | M | 64 | 7 years | |
| Craig Tooman | M | 58 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
| Michael Mulroy | M | 58 | - | |
| Gregory D. Flexter | M | 68 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
| Peter Edwards | M | 62 | 5 years | |
| Mario David Saltarelli | M | 63 | 2 years | |
| Thomas J. Koob | M | 74 | 14 years | |
| Chuck Koob | M | 79 | 12 years | |
| Steve Cartt | M | 61 | - | |
| Thomas Smith | M | 63 | 2 years | |
| Rohit Kashyap | M | 53 | 3 years | |
| Gary Phillips | M | 58 | - | |
| John J. Howarth | M | - | 2 years | |
| Rolf Classon | M | 79 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 43 | 62.32% |
| United States | 26 | 37.68% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Giuliani
- Personal Network
